E-Greetings from the Allergy Advocacy Association

April 2020

Spring greetings! We hope this finds you staying healthy and enjoying some quality time with your family as we weather the coronavirus crisis. We certainly appreciate all the efforts of our medical personnel and first responders who work every day to help those in need while risking their own health and safety.

In this issue we provide links to some webinars with detailed medical information about the nature of the coronavirus and practical treatment suggestions for allergy and asthma suffers who are exposed to COVID-19. There is also an alert regarding Epi-Pen© that might be defective, and we provide instructions on how to inspect them after purchasing.

We are thinking of you every day and can’t wait to get back to providing our educational seminars and training. There is light at the end of the tunnel!

Now What? A Layman’s Appraisal of Covid-19…

We hate to pile on with the doom and gloom, but this article describes the current situation and all the possible after-effects on such things as funding for charitable causes. Since asthma sufferers might be at increased risk if exposed to the virus, we are including links to some excellent webinars for all on practical treatment suggestions to those exposed to COVID-19. Meanwhile we remain hopeful about upcoming legislation at both the federal and state levels to address the specific needs of those living with severe allergies such as requiring training and awareness at restaurants.

As we hear more positive news about medications that work as well as vaccines, we will be sure to pass it on!

Now What? A Layman’s Appraisal of Covid-19…

Allergy Advocacy Association Logo Covid-19 Question Marks

…how it effects Allergy Advocacy and….well, everything else, too

By Jon Terry, founder
April 14th, 2020

Greetings.  At this time of international crisis, I sincerely hope all our readers are healthy and safe.

The coronavirus pandemic has impacted almost everyone around the globe.  So many serious questions remain unanswered. How many lives will be lost? How many more individuals will become infected?  How long will so many people need intensive medical care?  When will the number of people at risk for COVID-19 begin to decline? (Who knows?)

Continue Reading

Families with Food Allergies Struggle with Bare Shelves

It’s hard enough for those who have multiple food allergies to find products that are safe for them to eat, but with many grocery shelves now empty, the challenge is even greater. Read here about many families who are struggling to find the foods they know are safe due to the hoarding and stocking up by others. Please keep your fellow allergy sufferers in mind and only buy what you need. Food manufacturers are trying to keep up with the demand, and you may be able to buy directly from them if the need arises.

Families with Food Allergies Struggle with Bare Shelves

Scant offerings at a grocery store in Brooklyn last month.
Photo credit...Sarah Blesener for The New York Times

As the coronavirus spreads and locked-down communities stock up, products needed by allergy sufferers are increasingly hard to come by.

By Eric Athas
April 7, 2020

Like many Americans these days, Lisa M. Delmont is kept up at night by worry. But for Ms. Delmont, it’s the empty grocery store shelves that bring on dread.

Her 2-year-old son, Benjamin, is severely allergic to milk, eggs, cashews, pistachios and bananas, so she has to be judicious about the items she brings home. Exposure to the wrong food could send Benjamin into anaphylactic shock, something that has happened three times since he was born.

Continue Reading

Study: Recurring Anaphylaxis Often Follows the Same Progression in Individuals

In this helpful article, researchers report that the large majority of people who experience recurrent anaphylaxis will suffer the exact same sequence of symptoms and reactions. So if one starts to experience symptoms of an allergic reaction, they will know to seek help immediately and administer an epinephrine auto-injector (EAI) device. Medical practitioners can teach their patients to recognize their unique symptoms to allow them to earlier identify anaphylaxis and administer therapeutic interventions.

Study: Recurring Anaphylaxis Often Follows the Same Progression in Individuals


By Dave Bloom SnackSafely.com

In a study published in the Journal of Allergy and Clinical Immunology, researchers at the University of Toronto sought to determine whether people who suffered recurring anaphylaxis had a similar progression of symptoms each time.

They looked at records from patients seen at a tertiary care allergy clinic from 2012-2018 and analyzed the sequence of symptoms recorded from each patient. They included only the episodes of anaphylaxis to a single allergen, leaving records for 3,174 anaphylactic reactions in 162 patients. These patients ranged from 1-71 years of age with 77% being female.

Continue Reading

FDA: Inspect Epinephrine Auto-injectors to Head Off Problem

Attention all EpiPen users! The FDA has found defects in certain models of the Epi-Pen© and is strongly urging all users to closely inspect their pens as soon as they are purchased. This article lists in detail what defects to look for, such as making sure the blue safety release is not raised and that they can remove the device easily from the carrier tube. Tips are also provided regarding user errors that prevent the device from operating properly. You can get a free replacement from Mylan if your device appears to be defective by calling the number below.

FDA: Inspect Epinephrine Auto-injectors to Head Off Problem

American Academy of Pediatrics logo

By Trisha Korioth, Staff Writer
AAP News
March 25, 2020

The Food and Drug Administration (FDA) is warning that EpiPen 0.3 mg, EpiPen Jr. 0.15 mg and the authorized generic versions of the epinephrine products may have delayed injection or be prevented from proper injection.

The FDA urges people to inspect their epinephrine auto-injectors before a life-threatening emergency to make sure the blue safety release is not raised and that they can remove the device easily from the carrier tube.

Pfizer and Mylan issued a letter to health care providers on March 23 involving the brand and generic versions.

Continue Reading

The information provided on this site is in no way intended to be a substitute for medical advice,
diagnosis, or treatment with a licensed physician.
The Allergy Advocacy Association is a 501(c)(3) non-profit, tax-exempt organization.
Copyright 2020 © Allergy Advocacy Association, Inc. All rights reserved.  Terms & Conditions